FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York US FDA is expected to lift restriction on certain peptides, NYT reports Reuters Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to